Is Amniotics AB (publ) (AMNI.ST) a Buy, Sell, or Hold?
STO : AMNI.ST
Amniotics AB (publ)
$0.0054 SEK
$0.0 (5.88%)
- Volume
- 6.96M
- Average Volume
- 5.23M
- Market Capitalization
- $14.76M
- P/E Ratio
- -0.49
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.05
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.17
Company Overview
STO
Marcus Larsson
Biotechnology
Healthcare
AMNI.ST
4
SE
SEK
Liquidity Metrics
0.17
1.17
1.12
0.78
0.00
Sales & Valuation
-$
0.00
0.98
-0.46
-0.01
Profitability
-$0.011
-$30.87M
0.00%
0.00%
-362.71%
-118.34%
P/E Metrics
-0.49
-0.01
-0.01
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-7.62
2/9
$1.82M
$26.09M
$10.55M
-$28.86M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Marcus Larsson | Founding Member, Chief Executive Officer & Director |
| Sidonie Karlsson | Head of Manufacturing |
| Gerton Jonsson | Chief Financial Officer |
| Jan Talts | Chief Operating Officer |
Poll Results
No votes yet today — be the first to share your view!
About Amniotics AB (publ) (STO:AMNI.ST) Stock
Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden. ...
Frequently Asked Questions
-
What is the current Amniotics AB (publ) (AMNI.ST) stock price?
-
Amniotics AB (publ)(STO:AMNI.ST) stock price is $0.0054 in the last trading session. During the trading session, AMNI.ST stock reached the peak price of $0.0456 while $0.0012 was the lowest point it dropped to. The percentage change in AMNI.ST stock occurred in the recent session was 5.88% while the dollar amount for the price change in AMNI.ST stock was $0.0.
-
AMNI.ST's industry and sector of operation?
-
The STO listed AMNI.ST is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AMNI.ST?
-
Marcus Larsson | Founding Member, Chief Executive Officer & Director
Sidonie Karlsson | Head of Manufacturing
Gerton Jonsson | Chief Financial Officer
Jan Talts | Chief Operating Officer
| -
How many employees does AMNI.ST have?
-
Number of AMNI.ST employees currently stands at 4. AMNI.ST operates from ScheelevAegen 2, Lund, None 22381, SE.
-
Link for AMNI.ST official website?
-
Official Website of AMNI.ST is: https://www.amniotics.com
-
How do I contact AMNI.ST?
-
AMNI.ST could be contacted at phone #46 7 23 27 85 20 and can also be accessed through its website. AMNI.ST operates from ScheelevAegen 2, Lund, None 22381, SE.
-
How many shares of AMNI.ST are traded daily?
-
The average number of AMNI.ST shares traded daily for last 3 months was 5.23M.
-
What is the market cap of AMNI.ST currently?
-
The market value of AMNI.ST currently stands at $14.76M with its latest stock price at $0.0054